Viewing Study NCT04739800

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 12:17 PM
Ignite Modification Date: 2026-01-13 @ 6:01 PM
Study NCT ID: NCT04739800
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-04
First Post: 2021-02-04
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Fallopian Tube Mucinous Adenocarcinoma View
None Ovarian Seromucinous Carcinoma View
None Platinum-Refractory Fallopian Tube Carcinoma View
None Platinum-Refractory Ovarian Carcinoma View
None Platinum-Refractory Primary Peritoneal Carcinoma View
None Recurrent Fallopian Tube Clear Cell Adenocarcinoma View
None Recurrent Fallopian Tube Endometrioid Adenocarcinoma View
None Recurrent Fallopian Tube High Grade Serous Adenocarcinoma View
None Recurrent Fallopian Tube Mucinous Adenocarcinoma View
None Recurrent Fallopian Tube Transitional Cell Carcinoma View
None Recurrent Fallopian Tube Undifferentiated Carcinoma View
None Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma View
None Recurrent Ovarian Clear Cell Adenocarcinoma View
None Recurrent Ovarian Endometrioid Adenocarcinoma View
None Recurrent Ovarian High Grade Serous Adenocarcinoma View
None Recurrent Ovarian Low Grade Serous Adenocarcinoma View
None Recurrent Ovarian Mucinous Adenocarcinoma View
None Recurrent Ovarian Seromucinous Carcinoma View
None Recurrent Ovarian Transitional Cell Carcinoma View
None Recurrent Ovarian Undifferentiated Carcinoma View
None Recurrent Platinum-Resistant Fallopian Tube Carcinoma View
None Recurrent Platinum-Resistant Ovarian Carcinoma View
None Recurrent Platinum-Resistant Primary Peritoneal Carcinoma View
None Recurrent Primary Peritoneal Clear Cell Adenocarcinoma View
None Recurrent Primary Peritoneal Endometrioid Adenocarcinoma View
None Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma View
None Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma View
None Recurrent Primary Peritoneal Transitional Cell Carcinoma View
None Recurrent Primary Peritoneal Undifferentiated Carcinoma View
None Refractory Fallopian Tube Clear Cell Adenocarcinoma View
None Refractory Fallopian Tube Endometrioid Adenocarcinoma View
None Refractory Fallopian Tube High Grade Serous Adenocarcinoma View
None Refractory Fallopian Tube Mucinous Adenocarcinoma View
None Refractory Fallopian Tube Transitional Cell Carcinoma View
None Refractory Fallopian Tube Undifferentiated Carcinoma View
None Refractory Low Grade Fallopian Tube Serous Adenocarcinoma View
None Refractory Ovarian Clear Cell Adenocarcinoma View
None Refractory Ovarian Endometrioid Adenocarcinoma View
None Refractory Ovarian High Grade Serous Adenocarcinoma View
None Refractory Ovarian Low Grade Serous Adenocarcinoma View
None Refractory Ovarian Mucinous Adenocarcinoma View
None Refractory Ovarian Seromucinous Carcinoma View
None Refractory Ovarian Transitional Cell Carcinoma View
None Refractory Ovarian Undifferentiated Carcinoma View
None Refractory Primary Peritoneal Clear Cell Adenocarcinoma View
None Refractory Primary Peritoneal Endometrioid Adenocarcinoma View
None Refractory Primary Peritoneal High Grade Serous Adenocarcinoma View
None Refractory Primary Peritoneal Low Grade Serous Adenocarcinoma View
None Refractory Primary Peritoneal Transitional Cell Carcinoma View
None Refractory Primary Peritoneal Undifferentiated Carcinoma View
Keywords: